Hero Image

5 New Migraine Treatments That Could Change Your Life in 2025

Migraines aren’t just headaches—they’re disabling neurological events that can disrupt every aspect of your life. Fortunately, advances in medicine over the last few years have brought a wave of innovative migraine treatments, many of which offer faster relief, fewer side effects, and better prevention. If you've tried traditional therapies without success, these new migraine solutions in 2025 could be the game-changer you've been waiting for.

Here are five of the newest and most promising migraine treatments, including Zavzpret—and a fifth option that just might surprise you.

1. Zavzpret (Zavegepant Nasal Spray)

Approved by the FDA in 2023, Zavzpret is the first and only CGRP receptor antagonist nasal spray for acute migraine treatment.

Benefits:

  • Works in as little as 15 minutes
  • Easy-to-use nasal spray—ideal for patients who struggle with swallowing pills
  • Non-opioid, non-addictive
  • Fewer side effects than triptans

Zavzpret is an excellent option for people who need fast relief on the go or can’t tolerate traditional oral medications.

2. Vyepti (Eptinezumab-jjmr)

Vyepti is a preventive migraine treatment delivered via IV infusion every 3 months. It’s a CGRP monoclonal antibody that targets one of the key pathways involved in migraine attacks.

Benefits:

  • Reduces the number of monthly migraine days
  • Works within 24 hours of first infusion
  • Only requires treatment four times per year
  • Suitable for chronic and episodic migraine sufferers

Vyepti is ideal for people looking for long-term control with minimal maintenance.

3. Nerivio® Wearable Device

Nerivio is an FDA-approved neuromodulation device worn on the upper arm to treat migraines using remote electrical stimulation.

Benefits:

  • Drug-free and non-invasive
  • Controlled via smartphone app
  • Can be used during a migraine to reduce pain and related symptoms
  • Approved for teens and adults

This is a solid option for those who prefer natural or medication-free treatments, especially if they experience frequent side effects from pills.

4. Qulipta (Atogepant)

Qulipta is a once-daily oral CGRP inhibitor used for preventive treatment of episodic migraines.

Benefits:

  • Daily pill with no need for injections or infusions
  • Reduces migraine frequency and intensity over time
  • Minimal side effects (compared to older preventive meds like beta blockers or anti-seizure drugs)

For people who experience 4–14 migraines a month, Qulipta offers a powerful yet convenient preventive option.

5. Psilocybin Microdosing (Experimental Treatment)

This may be the most surprising migraine treatment gaining traction: microdosing psilocybin, the active compound in "magic mushrooms." Early studies suggest it may help reduce migraine frequency and severity, especially in cluster headache sufferers.

Benefits:

  • May affect serotonin receptors and inflammation in the brain
  • Early research shows promise for long-term migraine reduction
  • Non-hallucinogenic doses when taken in microdoses

While not yet FDA-approved, clinical trials are ongoing, and many patients report dramatic improvements when other treatments failed.

Conclusion

Migraine care has entered a new era, offering more than just painkillers and outdated meds. From fast-acting sprays like Zavzpret, to wearables and promising psychedelic research, today’s treatments offer targeted relief, prevention, and fewer side effects. If your current plan isn’t working, talk to your doctor about these new options—you could finally find the solution that works for you.

Sources

Pfizer – https://www.pfizer.com/products/product-detail/zavzpret

Nerivio – https://nerivio.com

National Headache Foundation – https://headaches.org

FDA – https://www.fda.gov

ClinicalTrials.gov – https://clinicaltrials.gov